Is peptide therapy FDA approved?

Peptide therapy is not FDA-approved as a category, because the FDA does not approve types of treatment. It approves individual drugs for specific uses after reviewing evidence from clinical trials. Dozens of peptide drugs have met that standard, including insulin, semaglutide (Ozempic and Wegovy), tirzepatide (Mounjaro and Zepbound), tesamorelin (Egrifta) and bremelanotide (Vyleesi). Many peptides promoted for wellness have not, including BPC-157, TB-500, ipamorelin and CJC-1295. Compounded peptides are not FDA-approved either, even when they contain the same active ingredient as an approved drug, because the FDA does not check compounded drugs for safety, effectiveness or quality before they are sold. In an October 2026 interim policy, HHS said it does not intend to take enforcement action against licensed pharmacies and physicians that compound six peptides, including BPC-157, for patient-specific prescriptions under set conditions while FDA completes rulemaking. That is enforcement discretion, not approval.

An approval covers a specific product for the uses on its label. The same molecule can carry separate approvals: semaglutide is approved as Ozempic for type 2 diabetes and as Wegovy for chronic weight management, each with its own label, dosing and warnings. Some approvals are narrow. Bremelanotide (Vyleesi) is approved only for acquired, generalized hypoactive sexual desire disorder in premenopausal women.

Once a drug is approved, a doctor generally may prescribe it for another use when they judge it medically appropriate for the patient. That is common, but the approval does not stretch to cover the new use, because the FDA has not reviewed evidence for it. So the useful question about any peptide is approved as what, and for what.

Compounded medicines are not FDA-approved, whether a 503A pharmacy makes them for an individual prescription or a 503B outsourcing facility makes them in bulk. Federal law also limits which bulk ingredients a 503A pharmacy may use, and most wellness peptides do not meet those conditions. On October 28, 2026 HHS issued an interim policy: until FDA finishes rulemaking on each substance, HHS does not intend to take enforcement action against state-licensed pharmacies, federal facilities or licensed physicians that compound BPC-157, epitalon, KPV, MOTS-c, semax or TB-500 for a patient-specific prescription under the policy’s conditions. That is enforcement discretion, not FDA approval: none of the six is FDA-approved or on the 503A bulks list. Our compounding status page tracks where each substance stands.

Peptides sold online as "research use only" are not approved for human use at all, and no regulator checks what is in the vial before it is sold. Our page on research-use-only peptides explains the risks, and the peptide regulatory tracker follows each substance as the rules change.

Checked October 30, 2026. Labels, guidelines and coverage rules change, so confirm anything that affects your care with your clinician or pharmacist.

• FDA: Development and approval process for drugs.
• FDA: Understanding Unapproved Use of Approved Drugs "Off Label".
• FDA: Compounding and the FDA, Questions and Answers ("Compounded drugs are not FDA-approved").
• HHS - Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances (issued October 28, 2026). Notice of availability, Federal Register, published October 30, 2026.
• DailyMed - OZEMPIC (semaglutide) injection prescribing information.
• DailyMed - WEGOVY (semaglutide) injection and tablets prescribing information.
• DailyMed - RYBELSUS (semaglutide) tablets prescribing information.
• DailyMed - ZEPBOUND (tirzepatide) prescribing information.
• DailyMed - EGRIFTA SV (tesamorelin) prescribing information.
• DailyMed - VYLEESI (bremelanotide) injection prescribing information.
• Drugs@FDA: FDA-approved drug products.

More from the Peptide Therapy FAQ: Can you take peptides orally? · Are peptides steroids? · How long has peptide therapy been around? · Which peptides are FDA-approved? · Peptide regulatory tracker · Does peptide therapy work?

Educational information from LiveNow Longevity, not medical advice. It gives no doses and does not replace an evaluation by a licensed clinician who knows your history.